Drug Information Association to Shine Light on Newly Released PCAST Report
Published: Apr 17, 2013
HORSHAM, Pa.--(BUSINESS WIRE)--A consummate group of moderators and panelists will participate in an executive session at DIA’s 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science. The session, to be held on June 25 in Boston, will be hosted by the Tufts Center for the Study of Drug Development (CSDD) and focus on a report released in January by the President’s Council of Advisors on Science and Technology (PCAST). Included in the panel will be Bernard Munos, founder of InnoThink Center for Research in Biomedical Innovation, who was recently noted in FierceBiotech as one of the 25 most influential people in biopharma, and Dalvir Gill, CEO of TransCelerate Biopharma Inc.